OTCMarketsExpert

OTCMarketsExpert

Bristol-Myers Squibb ( BMY ), Bayer and Ono Pharmaceutical (OPHLY) have entered into a clinical collaboration agreement to evaluate the combination of Bayer's kinase inhibitor Stivarga and Bristol-Myers Squibb's / Ono's anti-PD-1 immune checkpoint inhibitor, Opdivo in patients with micro-satellite stable metastatic colorectal cancer, the most common form of mCRC....

OTCMarketsExpert

Google has been on a tear from the Dec lows, it has now hit the 786 retrace and has sold of quite quickly as a result. It had a initial inverse H@S on the macd and then on price action which provided a lovely opportunity to go long. Due to the increased fear of regulation on Big Tech and social media's role in the New Zealand massacre, sentiment has changed...